VenBio is a US-based life sciences venture capital firm founded in 2011 and headquartered in San Francisco. The firm focuses on investing in biotechnology and pharmaceutical companies developing novel therapeutics for unmet medical needs. It typically invests across early- and growth-stage biopharma companies, often from academic spinouts through clinical-stage development. VenBio manages large institutional funds and works closely with scientific and clinical experts to guide portfolio companies through regulatory and commercialization pathways. Its investment strategy is highly research-driven, emphasizing deep scientific diligence and long development-cycle healthcare innovation.